Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.01.16	Dual Therapeutics Announces Oncology Strategic Collaboration With Bristol-Myers (RTTNews)
05.01.16	Oncodesign, Bristol-Myers Enter Into Strategic Drug Discovery Collaboration (RTTNews)
23.12.15	Seattle Genetics, Bristol-Myers Initiate Phase 1/2 Trial Of ADCETRIS (RTTNews)
18.12.15	Bristol-Myers Squibb To Sell Its HIV R&D Portfolio To ViiV Healthcare (RTTNews)
01.12.15	Bristol-Myers : FDA Okays Blood-Cancer Drug Empliciti (RTTNews)
30.11.15	Bristol-Myers Gets Complete Response Letter For Opdivo; Addl. Data Sought (RTTNews)
24.11.15	BMY Says FDA OKs Opdivo As Single Agent For Untreated BRAF WT Advanced Melanoma (RTTNews)
24.11.15	BMY's Opdivo Gets High-Five, XBIT Slammed For Messing Up Study, SMMT On Ascent (RTTNews)
24.11.15	FDA Approves Bristol-Myers's Opdivo To Treat Advanced Form Of Kidney Cancer (RTTNews)
19.11.15	FDA Snubs AMAG, Bright Pathway For STEM, AVXL Surges, Be All Ears For OTIC (RTTNews)
16.11.15	Bristol-Myers Squibb Announces Data From Phase 3 ALLY-3+ Trial (RTTNews)
03.11.15	ACAD Gets FDA Date, Insight On BIND, Mega Deals Of Monday, PRTA On Track (RTTNews)
02.11.15	Bristol-Myers Squibb To Acquire Cardioxyl Pharma In Deal Worth Around $2 Bln (RTTNews)
29.10.15	GILD Files NDA For HCV Medicine, Canada Gets MonaLisa Touch, APRI Awaits Data (RTTNews)
29.10.15	FDA Approves Another Indication For Bristol-Myers' Yervoy (RTTNews)
29.10.15	FDA Oks Bristol-Myers' Yervoy To Reduce Risk Of Melanoma Returning After Surgery (RTTNews)
27.10.15	Bristol-Myers Squibb Q3 Results Beat Estimates; Raises 2015 Adj. EPS View (RTTNews)
27.10.15	Bristol-Myers Squibb Co. Reveals 14% Drop In Q3 Earnings (RTTNews)
23.10.15	Bristol-Myers Announces Results From Three-part Phase 2a Study Of BMS-955176 (RTTNews)
16.10.15	Bristol-Myers : NICE Recommends Daklinza To Treat Chronic HCV Infection (RTTNews)
15.10.15	Bristol-Myers, Five Prime Announce Agreement For CSF1R Antibody Program (RTTNews)
14.10.15	Innate Pharma Gets $5 Mln Milestone Payment From Bristol-Myers On Lirilumab (RTTNews)
12.10.15	LLY Fixing Depleted Pipeline, AMGN's Prolia Outdoes Rival, Opdivo In The News (RTTNews)
10.10.15	Cancer Drug Opdivo Wins Early FDA Approval For Yet Another Indication (RTTNews)
09.10.15	FDA Expands Nivolumab Lung Cancer Approval (RTTNews)
06.10.15	Bristol-Myers Squibb Gets FDA's Priority Review For Daklinza SNDAs (RTTNews)
06.10.15	Bristol-Myers Squibb To Pay $14 Mln To Settle SEC Probe Of China Bribery (RTTNews)
01.10.15	Bristol-Myers Receives FDA Approval For Opdivo + Yervoy Regimen - Quick Facts (RTTNews)
28.09.15	Opdivo In The Headlines, Lightlake On Course, FDA Approves 2 Diabetes Drugs (RTTNews)
28.09.15	Opdivo Demonstrates Long Term Survival Benefit In Patients With Lung Cancer (RTTNews)
26.09.15	Bristol-Myers Announces Positive Phase 3 Results For Kidney Cancer Drug (RTTNews)
16.09.15	Bristol-Myers Squibb's Opdivo Gets Breakthrough Therapy Status - Quick Facts (RTTNews)
10.09.15	Bristol-Myers: EC Approves Updated Label For Daklinza For Treatment Of HCV (RTTNews)
02.09.15	Bristol-Myers: FDA Accepts SBLA For Opdivo, Grants Priority Review (RTTNews)
02.09.15	Bristol-Myers Squibb: FDA Accepts SBLA For Opdivo; Grants Priority Review (RTTNews)
01.09.15	Bristol-Myers Squibb, AbbVie Say FDA Accepts Empliciti BLA For Priority Review (RTTNews)
01.09.15	Heat Biologics Initiates HS-110, PD-1 Combined Checkpoint Inhibitor Tiral (RTTNews)
31.08.15	Bristol-Myers Squibb Gains Rights To To Acquire Promedior And Its PRM-151 (RTTNews)
31.08.15	Telesta Gets FDA Date, Stellar To Be Uplisted To NASDAQ, BMY Inks Deal (RTTNews)
31.08.15	Bristol-Myers, QIMR Collaborate To Discover Novel Immuno-Oncology Antibodies (RTTNews)
20.08.15	Bristol-Myers: Health Canada Approves DAKLINZA For Treatment Of Hepatitis C (RTTNews)
17.08.15	R-Pharm US Acquires Breast Cancer Drug Ixempra From Bristol-Myers Squibb (RTTNews)
13.08.15	Bristol-Myers: FDA Approves U.S. Product Labeling Update For Sprycel (RTTNews)
10.08.15	UniQure Gets $53 Mln From Bristol-Myers Under Deal To Develop Gene Therapies (RTTNews)
30.07.15	Kyowa Hakko Kirin, Bristol-Myers Announce Immuno-Oncology Clinical Collaboration (RTTNews)
27.07.15	Bristol-Myers Says EMA Grants Accelerated Assessment Of MAA For Empliciti (RTTNews)
24.07.15	FDA Oks Daklinza For Use With Sofosbuvir To Treat HCV Genotype 3 Infections (RTTNews)
23.07.15	Bristol-Myers Slips To Q2 Loss, Lifts 2015 EPS Outlook - Quick Facts (RTTNews)
23.07.15	EARNINGS SUMMARY: Details of Bristol-Myers Squibb Co. Q2 Earnings Report (RTTNews)
22.07.15	Da Vinci Brightens Up ISRG, HZNP Sweetens DEPO Bid, ISIS Earns A Milestone (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester